Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes

Author： Jinnouchi Y. Yamagishi S. Takeuchi M. Ishida S. Jinnouchi Y. Jinnouchi J. Imaizumi T.

ISSN： 1591-8890

Source： Clinical and Experimental Medicine, Vol.6, Iss.4, 2006-12, pp. : 191-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Serum Levels of the Advanced Glycation End Products N^ε-Carboxymethyllysine and Pentosidine Are Not Influenced by Treatment with the Angiotensin Receptor II Type 1 Blocker Irbesartan in Patients with Type 2 Diabetic Nephropathy and Hypertension

Nephron Clin Pract, Vol. 108, Iss. 4, 2008-04 ,pp. : c291-c297

Karger

Access to resources Recommend Favorite

Circulating Levels of Advanced Glycation End Products in Diabetes Mellitus–Related Dementia

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 10, 2015-10 ,pp. : 2196-2198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 847-854

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end‐products in patients without pre‐existing lung injury

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 7, 2015-10 ,pp. : 1131-1138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of advanced glycation end products in placenta and concentration in maternal and umbilical serum in pre‐eclampsia

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 6, 2015-06 ,pp. : 843-849

John Wiley & Sons Inc

Access to resources Recommend Favorite